Moderna Expands Its mRNA Pipeline With Three New Development Programs

mRNA-1608 is a vaccine candidate against Herpes simplex virus (HSV) mRNA-1468 is a vaccine candidate against varicella-zoster virus (VZV) to reduce the rate of herpes zoster (shingles) mRNA-4359 is a new checkpoint cancer vaccine...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials